{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:13:33Z","timestamp":1765368813031},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.juro.2012.08.218","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T10:00:40Z","timestamp":1349690440000},"page":"1104-1109","source":"Crossref","is-referenced-by-count":3,"title":["A Synthetic Polyvalent Ligand for \u03b15\u03b21 Integrin Activates Components of the Urothelial Carcinoma Cell Response to Bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1097","volume":"189","author":[{"given":"Fanghong","family":"Chen","sequence":"first","affiliation":[{"name":"Departments of Urology and Anesthesiology (BW), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Departments of Urology and Anesthesiology (BW), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanLi","family":"Cao","sequence":"additional","affiliation":[{"name":"Departments of Urology and Anesthesiology (BW), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Wakim","sequence":"additional","affiliation":[{"name":"Departments of Urology and Anesthesiology (BW), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"See","sequence":"additional","affiliation":[{"name":"Departments of Urology and Anesthesiology (BW), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.08.218_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5489\/cuaj.10051","article-title":"Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy","volume":"4","author":"Kassouf","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.juro.2012.08.218_bib3","series-title":"Guideline for the Management of Non-muscle Invasive Bladder Cancer: (Stages Ta,T1, and Tis): Update","author":"Hall","year":"2007"},{"key":"10.1016\/j.juro.2012.08.218_bib4","first-page":"695","article-title":"Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer","volume":"20","author":"Sosnowski","year":"1994","journal-title":"Comp Ther"},{"key":"10.1016\/j.juro.2012.08.218_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance BCG immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized SWOG Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI114434","article-title":"Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa","volume":"85","author":"Kavoussi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.juro.2012.08.218_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-5-8","article-title":"BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking","volume":"5","author":"Chen","year":"2005","journal-title":"BMC Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0022-5347(17)38621-4","article-title":"Characterization of fibronectin attachment by a human transitional cell carcinoma line, T24","volume":"145","author":"Coplen","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.ju.0000067623.43110.4c","article-title":"BCG initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin","volume":"170","author":"Chen","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.1996.57","article-title":"Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma","volume":"73","author":"Saito","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2012.08.218_bib11","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.juro.2009.08.018","article-title":"MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin","volume":"182","author":"Chen","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.218_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.urolonc.2008.12.023","article-title":"p21 Expression by human urothelial carcinoma cells modulates the phenotypic response to BCG","volume":"28","author":"See","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2012.08.218_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.juro.2012.08.218_bib14","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1464-410X.2008.08274.x","article-title":"Bacille-Calmette Guerin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1","volume":"103","author":"See","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.218_bib15","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s00262-007-0397-x","article-title":"The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity","volume":"57","author":"Sinn","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2012.08.218_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/CJI.0b013e3181587d29","article-title":"CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity","volume":"31","author":"Mangsbo","year":"2008","journal-title":"J Immunother"},{"key":"10.1016\/j.juro.2012.08.218_bib17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1464-410X.2008.08235.x","article-title":"Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guerin","volume":"103","author":"Joraku","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.218_bib18","first-page":"2735","article-title":"Characterization of soluble fibronectin binding to bacille Calmette-Guerin","volume":"135","author":"Aslanzadeh","year":"1989","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.juro.2012.08.218_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R","article-title":"Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity","volume":"86","author":"Zhao","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2012.08.218_bib20","first-page":"181","article-title":"Integrins in cell adhesion and signaling","volume":"9","author":"Akiyama","year":"1996","journal-title":"Human Cell"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.08.218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:54:50Z","timestamp":1651200890000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.08.218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1016\/j.juro.2012.08.218"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.08.218","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}